Stay updated with breaking news from Michael Labarre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company known for its novel enzyme technology that targets the extracellular matrix, has recently witnessed a significant insider sell transaction.
On October 17, 2023, Michael Labarre, the Senior Vice President and Chief Technical Officer of Halozyme Therapeutics Inc (NASDAQ:HALO), sold 10,000 shares of the company.
Sixth graders from the Scotts Ridge Middle School chorus led by Michael LaBarre, delighted @Ridgefieldps BOE meeting. Watch it here =>